Rising Awareness in Developing Countries fueling the Asia Pacific Human Milk Fortifier Market
In recent years, infant nutrition has been one of the most lucrative markets in Asia Pacific. Rise in population, steady economic development, and increase in per capita income are among the major factors driving the market. People in countries such as China, India, and South Korea are highly concerned about their children’s health and well-being and are widely adopting human milk fortifiers to support their growth and development. The concept of human milk fortifiers is new to many people in emerging economies, and the increasing awareness among people is expected to create lucrative opportunities for the market growth. The human milk fortifier market is gaining significant traction owing to increasing awareness regarding the benefits of human milk fortifiers, such as promoting growth and bone development. Health associations in the developing countries are taking initiatives to boost overall growth and improve nutrition in preterm babies. For instance, in July 2021, NeoLacta Lifesciences announced the development of a 100% human milk fortifier in India as per the guidelines of the World Health Organization (WHO). The product aims to improve the quality of nutritional care for newborns.Thus, the rising awareness about human milk fortifiers in developing countries is expected to provide lucrative growth opportunities for the market during the forecast period.
Asia Pacific Human Milk Fortifier Market Overview
Increased awareness among parents and healthcare professionals about the nutritional benefits of human milk fortifiers is driving the demand for this product. Also, advances in neonatal care have improved the survival rates of premature infants, leading to a higher demand for human milk fortifiers. These fortifiers provide essential nutrients and promote better health outcomes for preterm babies. As disposable income levels rise in Asia Pacific, more parents can afford premium healthcare products, including human milk fortifiers. This has contributed to the market growth, as parents are willing to invest in products that can improve their child's health and well-being. Moreover, the expansion of healthcare infrastructure, including neonatal intensive care units (NICUs), across Asia Pacific has created a favorable environment for the human milk fortifier market growth. Hospitals and healthcare facilities are better equipped to provide specialized care for premature infants, contributing to the increased demand for human milk fortifiers.Asia Pacific Human Milk Fortifier Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Human Milk Fortifier Market Segmentation
The Asia Pacific human milk fortifier market is segmented based on form, distribution channel, and country. Based on form, the Asia Pacific human milk fortifier market is bifurcated into powder and liquid. The powder segment held a larger market share in 2023.Based on distribution channel, the Asia Pacific human milk fortifier market is bifurcated into online and offline. The offline segment held a larger market share in 2023.
Based on country, the Asia Pacific human milk fortifier market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific human milk fortifier market in 2023.
Abbott Laboratories, NeoLacta Lifesciences Pvt Ltd, Nestle SA, Prolacta Bioscience Inc, Lead Care International Ltd, Raptakos, Brett & Co Ltd, Danone SA, and Reckitt Benckiser Group Plc are some of the leading companies operating in the Asia Pacific human milk fortifier market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific human milk fortifier market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific human milk fortifier market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific human milk fortifier market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table of Contents
Companies Mentioned
- Abbott Laboratories
- Nestle SA
- Prolacta Bioscience Inc
- Raptakos, Brett & Co Ltd
- Danone SA
- Neolac Inc
- Reckitt Benckiser Group Plc
- NeoLacta Lifesciences Pvt Ltd
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 95 |
Published | November 2023 |
Forecast Period | 2023 - 2030 |
Estimated Market Value in 2023 | 79.53 Million |
Forecasted Market Value by 2030 | 159.05 Million |
Compound Annual Growth Rate | 10.4% |
Regions Covered | Asia Pacific |
No. of Companies Mentioned | 8 |